Epigenome evolution in relapsed acute myeloid leukemia

被引：0
|
作者：
Li, Sheng
Garrett-Bakelman, Francine E.
Chung, Stephen S.
Hricik, Todd
Rapaport, Franck
Patel, Jay
Dillon, Richard
Vijay, Priyanka
Brown, Anna L.
Perl, Alexander E.
Connon, Joy
Sanders, Mathijs A.
Valk, Peter J. M.
Bullinger, Lars
Luger, Selina
Becker, Michael W.
Lewis, Ian D.
To, Luen Bik
D'Andrea, Richard J.
Grimwade, David
Delwel, Ruud
Lowenberg, Bob
Dohner, Hartmut
Dohner, Konstanze
Guzman, Monica L.
Hassane, Duane C.
Roboz, Gail J.
Carroll, Martin
Park, Christopher Y.
Neuberg, Donna S.
Levine, Ross L.
Melnick, Ari M.
Mason, Christopher E.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-073
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
    Goswami, Meghali
    Gui, Gege
    Dillon, Laura W.
    Lindblad, Katherine E.
    Thompson, Julie
    Valdez, Janet
    Kim, Dong-Yun
    Ghannam, Jack Y.
    Oetjen, Karolyn A.
    Destefano, Christin B.
    Smith, Dana M.
    Tekleab, Hanna
    Li, Yeusheng
    Dagur, Pradeep
    Hughes, Thomas
    Marte, Jennifer L.
    del Rivero, Jaydira
    Klubo-Gwiezdzinksa, Joanna
    Gulley, James L.
    Calvo, Katherine R.
    Lai, Catherine
    Hourigan, Christopher S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [32] The Genetic Landscape of Relapsed Pediatric Acute Myeloid Leukemia
    Umeda, Masayuki
    Ma, Jing
    Hagiwara, Kohei
    Westover, Tamara
    Walsh, Michael P.
    Song, Guangchun
    Liu, Yanling
    Chen, Xiaolong
    Kolekar, Pandurang
    Tran, Quang
    Foy, Scott
    Maciaszek, Jamie L.
    Liu, Yen-Chun
    Hiltenbrand, Ryan
    Miller, Jonathan
    Rusch, Michael
    Wu, Gang
    Inaba, Hiroto
    Mullighan, Charles G.
    Zhang, Jinghui
    Rubnitz, Jeffrey E.
    Ma, Xiaotu
    Klco, Jeffery M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S282 - S282
  • [33] Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
    Lindblad, Katherine E.
    Thompson, Julie
    Gui, Gege
    Valdez, Janet
    Worthy, Tatyana
    Tekleab, Hanna
    Hughes, Tom
    Goswami, Meghali
    Oetjen, Karolyn
    Kim, Dong-Yun
    Dillon, Laura
    DeStefano, Christin
    Lai, Catherine E.
    Hourigan, Christopher S.
    BLOOD, 2018, 132
  • [34] Outcome of Refractory and Relapsed Patients with Acute Myeloid Leukemia
    Niederwieser, Dietger
    Krahl, Rainer
    Kahle, Christoph
    Scholl, Sebastian
    Wolf, Hans-Heinrich
    Cross, Michael
    Hegenbart, Ute
    Peter, Norma
    Niederwieser, Christian
    Florschuetz, Axel
    Reifenrath, Kolja F. B.
    Zojer, Niklas
    Junghanss, Christian
    Sayer, Herbert
    Schmidt, Volker
    Maschmeyer, Georg
    Hochhaus, Andreas
    Fischer, Thomas
    Al-Ali, Haifa Kathrin
    Heinicke, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 106 - 106
  • [35] Treatment for relapsed acute myeloid leukemia: what is new?
    Ofran, Yishai
    Rowe, Jacob M.
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (02) : 89 - 94
  • [36] Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia
    DiNardo, Courtney D.
    Cortes, Jorge E.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (02) : 265 - 272
  • [37] Cardiac chloroma in a patient with relapsed acute myeloid leukemia
    Distelmaier, L.
    Kharaman, A.
    Noppeney, R.
    Duehrsen, U.
    Nueckel, H.
    ONKOLOGIE, 2011, 34 : 85 - 85
  • [38] Relapsed acute myeloid leukemia: Why is there no standard of care?
    Ravandi, Farhad
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (03) : 253 - 259
  • [39] Relapsed/refractory acute myeloid leukemia: any progress?
    Schlenk, Richard F.
    Mueller-Tidow, Carsten
    Benner, Axel
    Kieser, Meinhard
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (06) : 467 - 473
  • [40] Novel strategies for relapsed and refractory acute myeloid leukemia
    Mato, Anthony R.
    Morgans, Alicia
    Luger, Selina M.
    CURRENT OPINION IN HEMATOLOGY, 2008, 15 (02) : 108 - 114
12345